FREM2 Antibody
Novus Biologicals, part of Bio-Techne | Catalog # NBP1-68843
Key Product Details
Species Reactivity
Human
Applications
Peptide ELISA
Label
Unconjugated
Antibody Source
Polyclonal Goat IgG
Concentration
0.5 mg/ml
Product Specifications
Immunogen
Peptide with sequence C-RLIRSEPTYNQPVQQ corresponding to internal region according to NP_997244.3.
Epitope
C-RLIRSEPTYNQPVQQ
Clonality
Polyclonal
Host
Goat
Isotype
IgG
Description
Please note, this antibody is considered Innovators Grade. Innovators Grade antibodies are generally unvalidated and require additional characterization for most new species/applications. Novus has made these antibodies available through our Innovators Reward program. Complete an online review with image, detailing your positive or negative results. In return, you receive a discount voucher for 100% of the purchase price of the reviewed product. Please contact us at innovators@novusbio.com for more details.
Applications for FREM2 Antibody
Application
Recommended Usage
Peptide ELISA
Detection limit 1:8000
Application Notes
WB: Not yet tested - Our standard WB protocol would not expect to reliably detect proteins as large as the calculated size of 351 kDa band according to NP_997244.3.
Formulation, Preparation, and Storage
Purification
Immunogen affinity purified
Formulation
Tris saline (20 mM Tris pH 7.3, 150 mM NaCl), 0.5% BSA
Preservative
0.02% Sodium Azide
Concentration
0.5 mg/ml
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at -20C. Avoid freeze-thaw cycles.
Background: FREM2
Alternate Names
ECM3 Homolog, FRAS1 Related Extracellular Matrix Protein 2
Entrez Gene IDs
341640 (Human)
Gene Symbol
FREM2
UniProt
Additional FREM2 Products
Product Documents for FREM2 Antibody
Product Specific Notices for FREM2 Antibody
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...